Reducing unnecessary antibiotic use for pneumonia patients
Official title: Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
Run by The Cleveland Clinic · NCT05568654 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing different ways to reduce unnecessary antibiotic use in pneumonia patients by using quick tests and help from pharmacists to see if it can lead to better treatment outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 12500 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 12 sites (Vero Beach, Florida and 11 other locations) |
| Trial ID | NCT05568654 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are admitted to a participating hospital with a diagnosis of pneumonia.
✕Probably not a fit
Patients who may not benefit include those admitted to intensive care within 24 hours, those receiving comfort care only, or those with known pathogens prior to admission.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to minimize the use of broad-spectrum antibiotics in patients with community-acquired pneumonia (CAP) by implementing rapid diagnostic testing and pharmacist-led de-escalation strategies. It will be conducted as a pragmatic, multicenter, cluster randomized controlled trial over three years, comparing four different approaches: rapid diagnostic testing, pharmacist-led de-escalation, a combination of both, and usual care. The goal is to enhance the accuracy of pathogen detection and improve antibiotic stewardship practices following negative culture results.
Why it matters
Potential benefit: If successful, this approach could significantly reduce unnecessary antibiotic exposure and improve patient outcomes in pneumonia treatment.
How similar studies have gone: Other studies have shown promise in reducing antibiotic overuse through targeted therapies, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for patient's records: 1. Men or women greater than or equal to 18 years of age 2. Admitted to a participating (i.e. enrolled and randomized) hospital 3. Admitting diagnosis of pneumonia Exclusion Criteria: 1. Admission to intensive care unit within 24 hours of hospital admission 2. Comfort care measures only 3. Cystic fibrosis 4. Discharged from an acute care hospital in the past week 5. Patients not eligible for empiric therapy due to a known pathogen (any positive blood or respiratory cultures in the 72 hours prior to admission)
Where it's running
-
Indian River Hospital
Vero Beach, Florida, United States Recruiting -
Weston Hospital/Cleveland Clinic Florida
Weston, Florida, United States Recruiting -
Akron General Hospital
Akron, Ohio, United States Recruiting -
Avon Hospital
Avon, Ohio, United States Recruiting -
Lutheran Hospital
Cleveland, Ohio, United States Recruiting -
Cleveland Clinic Main Campus
Cleveland, Ohio, United States Recruiting
Show 6 more locations
-
Euclid Hospital
Euclid, Ohio, United States Recruiting -
Fairview Hospital
Fairview Park, Ohio, United States Recruiting -
Marymount Hospital
Garfield Heights, Ohio, United States Recruiting -
Hillcrest Hospital
Mayfield Heights, Ohio, United States Recruiting -
Medina Hospital
Medina, Ohio, United States Recruiting -
South Pointe Hospital
Warrensville Heights, Ohio, United States Recruiting
Study contacts
- Principal investigator: Michael Rothberg, M.D. — The Cleveland Clinic
- Study coordinator: Michael Rothberg, M.D.
- Email: ROTHBEM@ccf.org
- Phone: 216-445-0719
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehospital point-of-care testing to help decide about hospital transport
This trial tests whether rapid blood tests done in the ambulance can help decide if a patient should be conveyed to the hospital.
-
How frailty affects outcomes in older people with pneumonia in the ER
This study will test whether a quick bedside frailty score (the Clinical Frailty Scale) can help predict short-term death and serious complications in people aged 65 and older who come to the emergency department with pneumonia.
-
Fever clinic tracking of acute respiratory infections
This project follows adults who come to a fever clinic with respiratory infections to see how their symptoms, test results, and outcomes change over time.
-
Reducing unnecessary antibiotics for urinary tract infections by improving urine collection
This study will test whether a bilingual (English and Spanish) animated video and pictorial flyer can help adults in safety‑net primary care give cleaner urine samples to reduce contaminated cultures and unnecessary antibiotic prescriptions.
-
MagIA H3S multiplex rapid blood test for HIV, hepatitis B and C, and syphilis
This project will test a single blood-based point-of-care test that checks for HIV, hepatitis B and C, and syphilis using serum or plasma samples from people at sites in Ivory Coast and Kenya.
-
Azithromycin versus doxycycline as atypical coverage for adults hospitalized with community-acquired pneumonia on a beta-lactam
This trial will test whether adding azithromycin or doxycycline to a beta-lactam works better and is safer for adults hospitalized with community-acquired pneumonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.